540 related articles for article (PubMed ID: 27256280)
1. Axillary radiotherapy in conservative surgery for early-stage breast cancer (stage I and II).
García Novoa A; Acea Nebril B; Díaz I; Builes Ramírez S; Varela C; Cereijo C; Mosquera Oses J; López Calviño B; Seoane Pillado MT
Cir Esp; 2016; 94(6):331-8. PubMed ID: 27256280
[TBL] [Abstract][Full Text] [Related]
2. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
3. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
Bing AU; Kerr GR; Jack W; Chetty U; Williams LJ; Rodger A; Dixon JM
Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099
[TBL] [Abstract][Full Text] [Related]
4. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
6. Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome.
Kuznetsova M; Graybill JC; Zusag TW; Hartsell WF; Griem KL
Radiology; 1995 Nov; 197(2):507-10. PubMed ID: 7480703
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
9. Different radiation techniques to deliver therapeutic dose to the axilla in patients with sentinel lymph node-positive breast cancer: Doses, techniques challenges and clinical considerations.
Wang S; Kirova YM; Shan SC; Cai G; Ou D; Cao L; Cai R; Chen JY
Cancer Radiother; 2018 Dec; 22(8):767-772. PubMed ID: 30523794
[TBL] [Abstract][Full Text] [Related]
10. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
11. Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up.
Spruit PH; Siesling S; Elferink MA; Vonk EJ; Hoekstra CJ
Radiat Oncol; 2007 Oct; 2():40. PubMed ID: 17971196
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
13. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
[TBL] [Abstract][Full Text] [Related]
14. Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.
Hoebers FJ; Borger JH; Hart AA; Peterse JL; Th EJ; Lebesque JV
Cancer; 2000 Apr; 88(7):1633-42. PubMed ID: 10738222
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
16. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
17. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
Fodor J; Polgár C; Németh G
Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
[TBL] [Abstract][Full Text] [Related]
18. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?
Martelli G; Miceli R; De Palo G; Coradini D; Salvadori B; Zucali R; Galante E; Marubini E
Cancer; 2003 Mar; 97(5):1156-63. PubMed ID: 12599220
[TBL] [Abstract][Full Text] [Related]
19. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
Vitucci C; Tirelli C; Graziano F; Santoro E
J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819
[TBL] [Abstract][Full Text] [Related]
20. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
